Daxor Corporation (DXR) News

Form N-CSRS - Certified Shareholder Report, Semi-Annual

Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network

Community Hospital Purchases BVA Analyzer With Focus on Improving Outpatient Heart Failure Care Oak Ridge, TN...

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]

Form N-2 - Registration statement for closed-end investment companies

Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer

Oak Ridge, TN, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...

Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide

Daxor's ezBVA Lab Service Spearheads Growth and Broader Market Adoption Oak Ridge, TN, Aug. 05, 2024 (GLOBE...

Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer

The Hematocrit Feature Will Be Integrated Into A Future Generation Blood Volume Analyzer (BVA) Oak Ridge, TN...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide

Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market Penetration Oak Ridge, TN, July 11...

Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting

Oak Ridge, TN, June 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...

Form 8-K - Current report